Telum Therapeutics
Entry
2020
Hold
6yr
Status
Active
Who owns Telum Therapeutics?
Telum Therapeutics is currently owned by Clave Mayor through Clave Innohealth FCR (2020 vintage), since 2020. Across its history, Telum Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-08-03
Most recent investor
Clave MayorClave Innohealth FCR · 2020 · Life Sciences VC
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2020 · present
SodenaActive
2020 · present(6yr) · Sodena Direct · 1991 · Growth
Clave MayorActive
2020 · present(6yr) · Clave Innohealth FCR · 2020 · Life Sciences VC
Invivo PartnersActive
2020 · present(6yr) · Invivo Ventures · 2019 · Life Sciences VC
More from Clave Innohealth FCR
Other portfolio companies in the same fund.
More Clave Mayor portfolio companies
From the same investor, across funds.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Telum Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Telum Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue